Entering text into the input field will update the search result below

New chief at ImmunoCellular Therapeutics

  • ImmunoCellular Therapeutics (OTCPK:IMUC) promotes SVP of Strategic Resources Anthony Gringeri, Ph.D. to CEO replacing Andrew Gengos who resigned. He joined the company in 2013 from ViaCyte where he was VP and Chief Development Officer.

Recommended For You

About IMUC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
IMUC--
EOM Pharmaceuticals Holdings, Inc.